Cna Financial Corp Recursion Pharmaceuticals, Inc. Transaction History

Cna Financial Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$7.83 - $13.6 $41,968 - $72,896	-5,360 Reduced 18.19%	24,112 $257,000
Q2 2022 Aug 09, 2022	BUY	$5.04 - $9.26 $4,032 - $7,408	800 Added 2.79%	29,472 $240,000
Q1 2022 May 10, 2022	BUY	$6.16 - $18.03 $17,802 - $52,106	2,890 Added 11.21%	28,672 $205,000
Q4 2021 Feb 11, 2022	BUY	$16.14 - $21.86 $149,295 - $202,205	9,250 Added 55.95%	25,782 $442,000
Q3 2021 Nov 12, 2021	BUY	$19.03 - $41.33 $58,993 - $128,123	3,100 Added 23.08%	16,532 $380,000
Q2 2021 Aug 12, 2021	BUY	$18.0 - $37.42 $241,776 - $502,625	13,432 New	13,432 $490,000

291

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.32B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.